Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics companies. Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.
| 6.7 | |
| 6.84 | |
| - | |
| 7.46 | |
| 7.15 | |
| 6.52-12.62 | |
| 263 M | |
| 38 833 K | |
| 563 M | |
| -5.9 | |
| 0.477 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Boule Diagnostics AB (publ) (STO:BOUL) as an investment opportunity by taking the expected future cash ...
While Boule Diagnostics AB (publ) (STO:BOUL) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 19% in the last quarter. But t...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
